Impact of Prior Bendamustine Exposure on Bispecific Antibody Treatment Outcomes in Patients with Relapsed/Refractory Follicular Lymphoma
2024; Elsevier BV; Volume: 144; Issue: Supplement 1 Linguagem: Inglês
10.1182/blood-2024-205671
ISSN1528-0020
AutoresGloria Iacoboni, Emil Ramsø Kyvsgaard, Victor Navarro Garces, David A. Russler‐Germain, Alejandro Martı́n, Philip A. Thompson, Dylan Therwhanger, Itziar Carro, David Quintela, Pilar Gómez, Evelyn Valencia, Gala Vega, Ana Jiménez Ubieto, Mariana Bastos‐Oreiro, Ángel Serna, Simon Husby, Beatriz De La Cruz, Jing Luan, Sergi Camarillas, Lucía Medina, Almudena Cabero, Raúl Córdoba, Miguel Canales, Francesc Bosch, Juan‐Manuel Sancho, Anna Maria Sureda Balari, Stephen J. Schuster, Martin Hutchings, Pere Barba, Pau Abrisqueta Costa,
Tópico(s)Chronic Lymphocytic Leukemia Research
Referência(s)